|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
238,172,000 |
Market
Cap: |
2.86(B) |
Last
Volume: |
2,152,571 |
Avg
Vol: |
1,324,858 |
52
Week Range: |
$11.61 - $23.84 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : 12.3 |
Insider 6 Months : 12.3 |
Insider 3/6 Months : 24.3 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Neogen and subsidiaries develop, manufacture and market a range of products and services dedicated to food and animal safety. Co.'s segments are: Food Safety, which is engaged in the production and marketing of diagnostic test kits and complementary products marketed to food and feed producers and processors to detect dangerous and/or unintended substances in food and animal feed; and Animal Safety, which is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, a range of agricultural biosecurity products such as rodenticides, cleaners, disinfectants and insecticides, and genomics services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
53,000 |
53,000 |
76,000 |
143,100 |
Total Buy Value |
$662,087 |
$662,087 |
$1,009,714 |
$2,211,696 |
Total People Bought |
4 |
4 |
5 |
9 |
Total Buy Transactions |
4 |
4 |
7 |
17 |
Total Shares Sold |
0 |
0 |
6,359 |
6,359 |
Total Sell Value |
$0 |
$0 |
$109,734 |
$109,734 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
4 |
4 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Herbert James L |
Director |
|
2020-04-03 |
4 |
S |
$63.10 |
$1,263,200 |
I/I |
(20,000) |
19,972 |
|
-17% |
|
Tobin James P |
Director |
|
2020-03-26 |
4 |
B |
$60.62 |
$44,495 |
D/D |
734 |
5,500 |
2.39 |
35% |
|
Adent John Edward |
President & CEO |
|
2020-03-25 |
4 |
B |
$58.24 |
$101,920 |
D/D |
1,750 |
16,080 |
2.81 |
27% |
|
Herbert James L |
Director |
|
2020-02-18 |
4/A |
AS |
$72.04 |
$1,052,863 |
D/D |
(14,614) |
89,456 |
|
- |
|
Herbert James L |
Director |
|
2020-02-18 |
4 |
AS |
$72.04 |
$6,444,840 |
D/D |
(89,456) |
89,456 |
|
1% |
|
Herbert James L |
Director |
|
2020-02-14 |
4 |
GD |
$72.76 |
$545,700 |
D/D |
7,500 |
104,070 |
|
- |
|
Lilly Jason Warren |
Vice President |
|
2020-02-14 |
4 |
S |
$72.75 |
$517,040 |
D/D |
(7,107) |
11,294 |
|
-7% |
|
Lilly Jason Warren |
Vice President |
|
2020-02-14 |
4 |
OE |
$60.43 |
$483,420 |
D/D |
8,000 |
18,401 |
|
- |
|
Herbert James L |
Director |
|
2020-02-13 |
4 |
GD |
$72.00 |
$1,080,000 |
D/D |
15,000 |
111,570 |
|
- |
|
Quinlan Steven J. |
Vice President & CFO |
|
2020-02-12 |
4 |
S |
$72.25 |
$64,953 |
D/D |
(899) |
13,470 |
|
-2% |
|
Quinlan Steven J. |
Vice President & CFO |
|
2020-02-12 |
4 |
OE |
$40.46 |
$36,376 |
D/D |
899 |
14,369 |
|
- |
|
Quinlan Steven J. |
Vice President & CFO |
|
2020-02-11 |
4 |
S |
$72.00 |
$871,417 |
D/D |
(12,103) |
13,470 |
|
-0% |
|
Quinlan Steven J. |
Vice President & CFO |
|
2020-02-11 |
4 |
OE |
$40.46 |
$489,718 |
D/D |
12,103 |
25,573 |
|
- |
|
Herbert James L |
Director |
|
2020-02-11 |
4 |
GD |
$72.13 |
$28,852 |
D/D |
400 |
156,570 |
|
- |
|
Herbert James L |
Director |
|
2020-02-10 |
4 |
AS |
$69.72 |
$2,091,543 |
D/D |
(30,000) |
126,570 |
|
2% |
|
Lilly Jason Warren |
Vice President |
|
2020-02-10 |
4 |
S |
$70.01 |
$498,471 |
D/D |
(7,120) |
10,401 |
|
-2% |
|
Lilly Jason Warren |
Vice President |
|
2020-02-10 |
4 |
OE |
$40.46 |
$295,187 |
D/D |
7,120 |
17,521 |
|
- |
|
Lilly Jason Warren |
Vice President |
|
2020-02-06 |
4 |
S |
$70.01 |
$103,055 |
D/D |
(1,472) |
10,401 |
|
-3% |
|
Lilly Jason Warren |
Vice President |
|
2020-02-06 |
4 |
OE |
$35.34 |
$58,162 |
D/D |
1,472 |
11,873 |
|
- |
|
Lilly Jason Warren |
Vice President |
|
2020-02-05 |
4 |
S |
$70.02 |
$272,518 |
D/D |
(3,892) |
10,401 |
|
-5% |
|
Lilly Jason Warren |
Vice President |
|
2020-02-05 |
4 |
OE |
$35.34 |
$137,543 |
D/D |
3,892 |
14,293 |
|
- |
|
Herbert James L |
Director |
|
2020-02-03 |
4 |
AS |
$68.31 |
$2,049,787 |
D/D |
(30,000) |
156,970 |
|
2% |
|
Reed Thomas H |
Director |
|
2020-01-24 |
4 |
S |
$69.76 |
$69,760 |
D/D |
(1,000) |
8,010 |
|
-2% |
|
Reed Thomas H |
Director |
|
2020-01-24 |
4 |
OE |
$67.72 |
$67,720 |
D/D |
1,000 |
9,010 |
|
- |
|
Boehm William T |
Director |
|
2020-01-16 |
4 |
S |
$70.00 |
$140,000 |
D/D |
(2,000) |
10,479 |
|
1% |
|
523 Records found
|
|
Page 5 of 21 |
|
|